Clover Health officer proposes $21K stock sale
The proposed sale is described as a non-discretionary sell-to-cover transaction for tax withholding tied to restricted stock unit vesting.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Clover Health Investments, Corp. officer Joseph Clay Thornton reported a proposed sale of 4,487 shares of Class A common stock, with an aggregate market value of $20,999.16, on October 15, 2026. The sale is listed as a 10b5-1 plan sale and is described as a non-discretionary “sell to cover” transaction for tax withholding tied to restricted stock unit vesting and settlement. Thornton also reported sales of 4,630 shares on July 15, 2026, and 17,775 shares on August 17, 2026.
Key Figures
Key Terms
10b5-1 Plan regulatory
Restricted Stock Units financial
sell to cover financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.